Lawmakers sharply split over LB 677 implementation as medical cannabis commission readies rules

Lincoln, Nebraska — The Nebraska Legislature spent a daylong floor debate on May 21 considering LB 677, a bill and committee amendment that would create a statutory regulatory framework for medical cannabis, with senators sharply divided over whether to implement rules in statute or leave regulation to the newly created Nebraska Medical Cannabis Commission.

Proponents of LB 677, including several senators who sponsored or helped craft the committee amendment, said the bill provides needed guardrails to make the medicine accessible and safe. “If we’re gonna say it’s medical, we treat it like medical,” Senator Hansen said on the floor, urging a regulatory structure he called conservative and patient-focused.

Opponents argued the two voter-approved ballot initiatives (Initiative 4-37 and Initiative 4-38) vest the authority to regulate medical cannabis exclusively in the Medical Cannabis Commission and that the legislature should confirm the governor’s nominees and let that body write the rules. “The power to regulate all phases of the control of the possession, manufacture, distribution, delivery and dispensing of cannabis for medical purposes … is vested exclusively in the commission,” Senator Storm said, quoting the statutory language from the initiative.

Why it matters: Voters approved two measures in November 2024 that legalized certain medical cannabis activities and directed creation of a Medical Cannabis Commission. The dispute before senators was procedural and practical: whether to adopt LB 677 now to establish statutory guardrails and tax/fee structures or to refrain and allow the commission, once confirmed and funded, to promulgate rules under the initiatives’ language.

Supporters said the bill prevents a regulatory vacuum and clarifies limits, fees and enforcement mechanisms. Senator John Kavanaugh, a backer of LB 677, said the ballot initiatives answered the basic question of whether medical cannabis should be legal and that the legislation answers how it will be made available and kept safe: “The question LB 677 is seeking to answer is how do we make it accessible and safe.” Senator McKinney and others emphasized patient stories and medical need during the debate.

Opponents cited litigation and state constitutional process. Senator Storm and others noted ongoing court challenges to signatures and other legal questions and said the initiative’s text gives the commission exclusive rulemaking power; they urged waiting on confirmations and rulings. Senator Dover and Senator Jacobson said the legislature’s only clear role under the initiatives is confirmation of the governor’s appointments, and that the commission must be given the opportunity to act.

Funding and timing were central points. Supporters pointed to legislative budget action and a governor’s announcement to provide administrative support: Governor Jim Pillen issued a public statement that the policy research office and Department of Administrative Services would provide administrative support to the commission and that he had appointed two members and urged the legislature to confirm them promptly. Opponents countered that the commission’s funding and capacity remained uncertain and that statutory language in LB 677 is needed to ensure an operational program.

Law enforcement and legal advisories also shaped the debate. Senator Storm and others distributed a letter from Attorney General Mike Hilgers and noted a separate letter signed by dozens of county sheriffs expressing opposition to the committee amendment; supporters urged senators to read the ballot-text and fiscal notes carefully and cautioned that some criticisms target the initiative language rather than the committee amendment.

Procedure and next steps: Senator Storm offered a priority motion to indefinitely postpone (IPP) LB 677; the motion was debated on the floor but no final disposition of the IPP was recorded in the transcript. General Affairs Committee Chair Senator Holcroft said the committee scheduled a confirmation hearing for the governor’s appointees to the Medical Cannabis Commission at 2:00 p.m. Thursday, May 22, and argued the committee moved a compromise amendment in part because the Liquor Control Commission executive director warned of limited ability to act without legislative direction and initial funding.

What was unresolved: The transcript records extensive debate but does not show a final vote on the IPP motion or final passage of LB 677. Senators on both sides offered possible amendments (including one discussed on the floor to delay implementation to allow pending litigation to proceed), and several senators asked for additional technical fixes addressing definitions, patient qualification lists, possession limits, civil/criminal immunity for recommending clinicians, and law-enforcement procedures.

The debate illustrated a larger question facing legislatures nationwide: how to translate voter-approved initiatives into detailed regulatory systems while balancing access, public safety, funding and legal risk. The commission, once confirmed and funded, is scheduled by the initiative’s timetable to begin granting registrations later in 2025, and the legislature faces choices about whether to set statutory guardrails now or allow the commission’s rulemaking to proceed first.